SCHG vs XLV
Schwab US Large-Cap Growth ETF vs Health Care Select Sector SPDR Fund
- • SCHG has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | SCHG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 0.40% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $61.69B | $49.10B |
YTD return | 4.82% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.19 | 0.41 |
P/E ratio | 27.01 | 30.63 |
Last price | $34.60 | $187.94 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHG top holdings
| AAPL | Apple Inc | 12.07% |
| NVDA | NVIDIA Corp | 11.88% |
| MSFT | Microsoft Corp | 9.30% |
| AMZN | Amazon.com Inc | 5.66% |
| AVGO | Broadcom Inc | 4.07% |
| GOOGL | Alphabet Inc Class A | 3.94% |
| META | Meta Platforms Inc Class A | 3.77% |
| GOOG | Alphabet Inc Class C | 3.17% |
| LLY | Eli Lilly and Co | 3.16% |
| TSLA | Tesla Inc | 3.14% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About SCHG
SCHG (Schwab US Large-Cap Growth ETF) is Large-cap US growth at low cost. Managed by Schwab, the fund carries $61.7B in assets under management, an expense ratio of 0.04%, a dividend yield of 0.40%. Its largest holding is Apple Inc (AAPL), which represents 12.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.3%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.